These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25819770)

  • 21. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.
    Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN
    Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4.
    Zhang J; Yang Y; Liu Y; Fan Y; Liu Z; Wang X; Yuan Q; Yin Y; Yu J; Zhu M; Zheng J; Lu X
    J Surg Res; 2014 Jun; 189(1):68-74. PubMed ID: 24650454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.
    Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O; Junaid TA
    Exp Mol Pathol; 2020 Apr; 113():104379. PubMed ID: 31935378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.
    Minna E; Romeo P; Dugo M; De Cecco L; Todoerti K; Pilotti S; Perrone F; Seregni E; Agnelli L; Neri A; Greco A; Borrello MG
    Oncotarget; 2016 Mar; 7(11):12731-47. PubMed ID: 26871295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
    Ortiz IMDP; Barros-Filho MC; Dos Reis MB; Beltrami CM; Marchi FA; Kuasne H; do Canto LM; de Mello JBH; Abildgaard C; Pinto CAL; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2018 Nov; 10(1):144. PubMed ID: 30454026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA Profiling in Papillary Thyroid Cancer.
    Armos R; Bojtor B; Papp M; Illyes I; Lengyel B; Kiss A; Szili B; Tobias B; Balla B; Piko H; Illes A; Putz Z; Kiss A; Toth E; Takacs I; Kosa JP; Lakatos P
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma.
    Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G
    Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of miR-146b-5p via iodine involvement repressed papillary thyroid carcinoma cell proliferation.
    Pan Y; Yun W; Shi B; Cui R; Liu C; Ding Z; Fan J; Jiang W; Tang J; Zheng T; Yu X; Liu Y
    J Mol Endocrinol; 2020 Aug; 65(2):1-10. PubMed ID: 32302969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 38. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis.
    Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O
    Cancer Biol Ther; 2020 May; 21(5):412-423. PubMed ID: 32037949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma.
    Zhang J; Liu Y; Liu Z; Wang XM; Yin DT; Zheng LL; Zhang DY; Lu XB
    Int J Med Sci; 2013; 10(5):585-92. PubMed ID: 23533107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy.
    Ye W; Deng X; Fan Y
    Neoplasma; 2019 Jul; 66(4):516-523. PubMed ID: 30868891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.